{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:01:02Z","timestamp":1787504462223,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.canlet.2013.09.020","type":"journal-article","created":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T01:52:22Z","timestamp":1379901142000},"page":"90-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["\u03b2-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation"],"prefix":"10.1016","volume":"343","author":[{"given":"Jung Min","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pippa","family":"Newell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sucha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Parwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari Nichole","family":"Nejak-Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satdarshan P.","family":"Monga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2013.09.020_b0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"Ca-a Cancer J. Clinic."},{"key":"10.1016\/j.canlet.2013.09.020_b0200","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2013.09.020_b0015","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/hep.24710","article-title":"Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992\u20132008","volume":"55","author":"Altekruse","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.09.020_b0020","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment","volume":"6","author":"Farazi","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2013.09.020_b0205","doi-asserted-by":"crossref","DOI":"10.1002\/hep.25674","article-title":"Chronic inflammation, immune escape and oncogenesis in the liver: a unique neighborhood for novel intersections","author":"Stauffer","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.09.020_b0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-2006-960171","article-title":"Genomics and signaling pathways in hepatocellular carcinoma","volume":"27","author":"Villanueva","year":"2007","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.canlet.2013.09.020_b0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semcancer.2010.12.010","article-title":"Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad","volume":"21","author":"Nejak-Bowen","year":"2011","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2013.09.020_b0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/B978-0-12-385233-5.00009-X","article-title":"Signaling networks in human hepatocarcinogenesis\u2013novel aspects and therapeutic options","volume":"97","author":"Breuhahn","year":"2010","journal-title":"Prog. Mol. Biol. Trans. Sci."},{"key":"10.1016\/j.canlet.2013.09.020_b0045","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/hep.21651","article-title":"WNT\/beta-catenin signaling in liver health and disease","volume":"45","author":"Thompson","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.09.020_b0050","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/sj.onc.1209824","article-title":"Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas","volume":"26","author":"Zucman-Rossi","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2013.09.020_b0055","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1038\/sj.onc.1202800","article-title":"Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity","volume":"18","author":"Legoix","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2013.09.020_b0060","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/hep.23538","article-title":"Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin","volume":"51","author":"Nejak-Bowen","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.09.020_b0065","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1053\/j.gastro.2004.04.062","article-title":"Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes","volume":"127","author":"Safadi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2013.09.020_b0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6890-6-4","article-title":"Primary histologic diagnosis using automated whole slide imaging: a validation study","volume":"6","author":"Gilbertson","year":"2006","journal-title":"BMC Clin. Pathol."},{"key":"10.1016\/j.canlet.2013.09.020_b0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00042737-200402000-00002","article-title":"Thioacetamide-induced hepatic fibrosis in transforming growth factor beta-1 transgenic mice","volume":"16","author":"Schnur","year":"2004","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2013.09.020_b0080","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.1038\/sj.onc.1206118","article-title":"New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism","volume":"21","author":"Cadoret","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2013.09.020_b0085","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/hep.22695","article-title":"Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene","volume":"49","author":"Cieply","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.09.020_b0090","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.devcel.2006.03.015","article-title":"Apc tumor suppressor gene is the \u201czonation-keeper\u201d of mouse liver","volume":"10","author":"Benhamouche","year":"2006","journal-title":"Dev. Cell"},{"key":"10.1016\/j.canlet.2013.09.020_b0095","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0002-9440(10)65168-1","article-title":"Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation","volume":"155","author":"Nhieu","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2013.09.020_b0100","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1053\/j.gastro.2006.08.042","article-title":"Conditional deletion of beta-catenin reveals its role in liver growth and regeneration","volume":"131","author":"Tan","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2013.09.020_b0105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/path.2169","article-title":"Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations","volume":"212","author":"Audard","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2013.09.020_b0110","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/hep.1840200320","article-title":"Changes in distribution and activity of glutamine synthetase in carbon tetrachloride-induced cirrhosis in the rat: potential role in hyperammonemia","volume":"20","author":"Gebhardt","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.09.020_b0115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/hep.20286","article-title":"Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver","volume":"40","author":"Ovejero","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.09.020_b0120","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1172\/JCI43937","article-title":"Oncogenic beta-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice","volume":"122","author":"Anson","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2013.09.020_b0125","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1038\/sj.onc.1204982","article-title":"Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors","volume":"20","author":"Aydinlik","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2013.09.020_b0130","doi-asserted-by":"crossref","first-page":"17216","DOI":"10.1073\/pnas.0404761101","article-title":"Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas","volume":"101","author":"Colnot","year":"2004","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2013.09.020_b0135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/0008-5472.CAN-03-2123","article-title":"Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations","volume":"64","author":"Harada","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2013.09.020_b0140","doi-asserted-by":"crossref","first-page":"14771","DOI":"10.1073\/pnas.0706578104","article-title":"Distinct pathways of genomic progression to benign and malignant tumors of the liver","volume":"104","author":"Tward","year":"2007","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2013.09.020_b0145","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nm.2667","article-title":"Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease","volume":"18","author":"Boulter","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2013.09.020_b0210","article-title":"Pten-mediated Akt\/beta-catenin\/Foxo1 signaling regulates innate immune responses in mouse liver ischemia\/reperfusion injury","author":"Kamo","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.09.020_b0155","doi-asserted-by":"crossref","unstructured":"N. Lehwald, G.Z. Tao, K.Y. Jang, M. Sorkin, W.T. Knoefel, K.G. Sylvester, Wnt-beta-catenin signaling protects against hepatic ischemia and reperfusion injury in mice, Gastroenterology 141 (2011) 707\u2013718 (718 e701\u2013705).","DOI":"10.1053\/j.gastro.2011.04.051"},{"key":"10.1016\/j.canlet.2013.09.020_b0215","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M112.388298","article-title":"Coordinated action of hypoxia-inducible factor-1alpha and beta-catenin in androgen receptor signaling","author":"Mitani","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2013.09.020_b0165","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.21467","article-title":"Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets","volume":"45","author":"Boyault","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.09.020_b0170","doi-asserted-by":"crossref","first-page":"e39771","DOI":"10.1371\/journal.pone.0039771","article-title":"Beta-Catenin loss in hepatocytes promotes hepatocellular cancer after diethylnitrosamine and phenobarbital administration to mice","volume":"7","author":"Awuah","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2013.09.020_b0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/carcin\/bgq226","article-title":"Tumor formation in liver of conditional beta-catenin-deficient mice exposed to a diethylnitrosamine\/phenobarbital tumor promotion regimen","volume":"32","author":"Rignall","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2013.09.020_b0180","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/hep.23747","article-title":"Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha\/phosphoinositide 3-kinase signaling","volume":"52","author":"Zhang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.09.020_b0185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.21068","article-title":"Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC","volume":"43","author":"Zucman-Rossi","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.09.020_b0190","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1158\/1055-9965.EPI-08-0821","article-title":"Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression","volume":"18","author":"Hoque","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.canlet.2013.09.020_b0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/carcin\/bgr239","article-title":"MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer","volume":"33","author":"Hirata","year":"2012","journal-title":"Carcinogenesis"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383513006745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383513006745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T15:52:05Z","timestamp":1539359525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383513006745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0304383513006745"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2013.09.020","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2013.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}